SCIENTIFIC REGRESS.

The article discusses the challenges facing contemporary science. It is said that 65 percent of psychology experiments failed to show statistical significance on replication, and the rest showed greatly reduced effect sizes. A group of researchers at Bayer in 2011 examined sixty-seven recent drug di...

Descripción completa

Detalles Bibliográficos
Publicado en:First Things: A Monthly Journal of Religion & Public Life no. 263; pp. 37 - 43
Autor principal: Wilson, William A.
Formato: Artículo
Publicado: Institute on Religion & Public Life May2016
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=hlh&AN=114517743&site=ehost-live
header:
  @attributes:
    shortDbName: hlh
    uiTerm: 114517743
    longDbName: Humanities International Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        10475141
        1W4
      jtl: First Things: A Monthly Journal of Religion & Public Life
      issn: 10475141
      maglogo: N
    pubinfo:
      dt: May2016
      iid: 263
      pid: 4122
      pub: Institute on Religion & Public Life
    artinfo:
      ui: 114517743
      ppf: 37
      ppct: 6
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
              size: 3.8MB
      tig:
        atl: SCIENTIFIC REGRESS.
      aug:
        au: Wilson, William A.
      su:
        Science
        Scientific literature
        Psychological experiments
        Psychological tests
        Data analysis
      sug:
        subj:
          Science
          Scientific literature
          Psychological experiments
          Psychological tests
          Data analysis
      ab: The article discusses the challenges facing contemporary science. It is said that 65 percent of psychology experiments failed to show statistical significance on replication, and the rest showed greatly reduced effect sizes. A group of researchers at Bayer in 2011 examined sixty-seven recent drug discovery projects and found that in more than 75 percent of cases the published data did not match up with their in-house attempts to replicate.
      pubtype: Periodical
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: Y
      custom: Copyright of First Things: A Monthly Journal of Religion & Public Life is the property of Institute of Religion & Public Life and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use.
      item: First Things: A Monthly Journal of Religion & Public Life
      holder: Institute of Religion & Public Life
      dt:
        @attributes:
          year: 2016
    holdings:
      @attributes:
        islocal: N